182 related articles for article (PubMed ID: 37550596)
21. Nuclear factor (erythroid-derived 2)-like 2 activation-induced hepatic very-low-density lipoprotein receptor overexpression in response to oxidative stress contributes to alcoholic liver disease in mice.
Wang Z; Dou X; Li S; Zhang X; Sun X; Zhou Z; Song Z
Hepatology; 2014 Apr; 59(4):1381-92. PubMed ID: 24170703
[TBL] [Abstract][Full Text] [Related]
22. NKG2D receptor activation of NF-κB enhances inflammatory cytokine production in murine effector CD8(+) T cells.
Whitman E; Barber A
Mol Immunol; 2015 Feb; 63(2):268-78. PubMed ID: 25089028
[TBL] [Abstract][Full Text] [Related]
23. Disruption of nuclear factor (erythroid-derived-2)-like 2 antioxidant signaling: a mechanism for impaired activation of stem cells and delayed regeneration of skeletal muscle.
Shelar SB; Narasimhan M; Shanmugam G; Litovsky SH; Gounder SS; Karan G; Arulvasu C; Kensler TW; Hoidal JR; Darley-Usmar VM; Rajasekaran NS
FASEB J; 2016 May; 30(5):1865-79. PubMed ID: 26839378
[TBL] [Abstract][Full Text] [Related]
24. Metabolic plasticity of human T cells: Preserved cytokine production under glucose deprivation or mitochondrial restriction, but 2-deoxy-glucose affects effector functions.
Renner K; Geiselhöringer AL; Fante M; Bruss C; Färber S; Schönhammer G; Peter K; Singer K; Andreesen R; Hoffmann P; Oefner P; Herr W; Kreutz M
Eur J Immunol; 2015 Sep; 45(9):2504-16. PubMed ID: 26114249
[TBL] [Abstract][Full Text] [Related]
25. The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism.
Lee SB; Sellers BN; DeNicola GM
Antioxid Redox Signal; 2018 Dec; 29(17):1774-1791. PubMed ID: 28899208
[TBL] [Abstract][Full Text] [Related]
26. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
27. Nrf2 expression and activity in human T lymphocytes: stimulation by T cell receptor activation and priming by inorganic arsenic and tert-butylhydroquinone.
Morzadec C; Macoch M; Sparfel L; Kerdine-Römer S; Fardel O; Vernhet L
Free Radic Biol Med; 2014 Jun; 71():133-145. PubMed ID: 24632381
[TBL] [Abstract][Full Text] [Related]
28. Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer.
Best SA; Gubser PM; Sethumadhavan S; Kersbergen A; Negrón Abril YL; Goldford J; Sellers K; Abeysekera W; Garnham AL; McDonald JA; Weeden CE; Anderson D; Pirman D; Roddy TP; Creek DJ; Kallies A; Kingsbury G; Sutherland KD
Cell Metab; 2022 Jun; 34(6):874-887.e6. PubMed ID: 35504291
[TBL] [Abstract][Full Text] [Related]
29. Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism.
Smolková K; Mikó E; Kovács T; Leguina-Ruzzi A; Sipos A; Bai P
Antioxid Redox Signal; 2020 Nov; 33(13):966-997. PubMed ID: 31989830
[No Abstract] [Full Text] [Related]
30. Nrf2 promotes oesophageal cancer cell proliferation via metabolic reprogramming and detoxification of reactive oxygen species.
Kitano Y; Baba Y; Nakagawa S; Miyake K; Iwatsuki M; Ishimoto T; Yamashita YI; Yoshida N; Watanabe M; Nakao M; Baba H
J Pathol; 2018 Mar; 244(3):346-357. PubMed ID: 29243822
[TBL] [Abstract][Full Text] [Related]
31. Reductive carboxylation epigenetically instructs T cell differentiation.
Jaccard A; Wyss T; Maldonado-Pérez N; Rath JA; Bevilacqua A; Peng JJ; Lepez A; Von Gunten C; Franco F; Kao KC; Camviel N; Martín F; Ghesquière B; Migliorini D; Arber C; Romero P; Ho PC; Wenes M
Nature; 2023 Sep; 621(7980):849-856. PubMed ID: 37730993
[TBL] [Abstract][Full Text] [Related]
32. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.
Ungvari Z; Bagi Z; Feher A; Recchia FA; Sonntag WE; Pearson K; de Cabo R; Csiszar A
Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H18-24. PubMed ID: 20418481
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Control of CD8
Zhang L; Romero P
Trends Mol Med; 2018 Jan; 24(1):30-48. PubMed ID: 29246759
[TBL] [Abstract][Full Text] [Related]
34. CD4+ T cell-derived IL-2 signals during early priming advances primary CD8+ T cell responses.
Lai YP; Lin CC; Liao WJ; Tang CY; Chen SC
PLoS One; 2009 Nov; 4(11):e7766. PubMed ID: 19901991
[TBL] [Abstract][Full Text] [Related]
35. Nrf2 Activation Protects Mouse Beta Cells from Glucolipotoxicity by Restoring Mitochondrial Function and Physiological Redox Balance.
Schultheis J; Beckmann D; Mulac D; Müller L; Esselen M; Düfer M
Oxid Med Cell Longev; 2019; 2019():7518510. PubMed ID: 31827698
[TBL] [Abstract][Full Text] [Related]
36. Dimethyl Fumarate Controls the NRF2/DJ-1 Axis in Cancer Cells: Therapeutic Applications.
Saidu NE; Noé G; Cerles O; Cabel L; Kavian-Tessler N; Chouzenoux S; Bahuaud M; Chéreau C; Nicco C; Leroy K; Borghese B; Goldwasser F; Batteux F; Alexandre J
Mol Cancer Ther; 2017 Mar; 16(3):529-539. PubMed ID: 28069874
[TBL] [Abstract][Full Text] [Related]
37. Glucose availability is a decisive factor for Nrf2-mediated gene expression.
Heiss EH; Schachner D; Zimmermann K; Dirsch VM
Redox Biol; 2013; 1(1):359-65. PubMed ID: 24024172
[TBL] [Abstract][Full Text] [Related]
38. Luteolin prevents liver from tunicamycin-induced endoplasmic reticulum stress via nuclear factor erythroid 2-related factor 2-dependent sestrin 2 induction.
Jegal KH; Kim EO; Kim JK; Park SM; Jung DH; Lee GH; Ki SH; Byun SH; Ku SK; Cho IJ; Kim SC
Toxicol Appl Pharmacol; 2020 Jul; 399():115036. PubMed ID: 32407927
[TBL] [Abstract][Full Text] [Related]
39. Nuclear factor E2-related factor-2 has a differential impact on MCT1 and MCT4 lactate carrier expression in colonic epithelial cells: a condition favoring metabolic symbiosis between colorectal cancer and stromal cells.
Diehl K; Dinges LA; Helm O; Ammar N; Plundrich D; Arlt A; Röcken C; Sebens S; Schäfer H
Oncogene; 2018 Jan; 37(1):39-51. PubMed ID: 28846107
[TBL] [Abstract][Full Text] [Related]
40. GITR Agonism Enhances Cellular Metabolism to Support CD8
Sabharwal SS; Rosen DB; Grein J; Tedesco D; Joyce-Shaikh B; Ueda R; Semana M; Bauer M; Bang K; Stevenson C; Cua DJ; Zúñiga LA
Cancer Immunol Res; 2018 Oct; 6(10):1199-1211. PubMed ID: 30154083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
